HUM Earnings

HUM reported its earnings on 2026-04-29, showcasing a revenue of 39.65B against an estimate of 39.45B, resulting in a 0.5% surprise. The EPS was 10.31, surpassing the expected 9.97 by 3.41%. The stock experienced a 5.83% price change on the earnings day and a 3.59% change over the next five days, reflecting market reactions to the results.

Following HUM's earnings announcement on 2026-04-29, the stock price moved by 5.83% on the day of the release. Over the subsequent five days, it saw a 3.59% change. Historically, HUM's stock price tends to shift by an average of 5.2% in the 10 days leading up to earnings and 1.51% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate HUM's annual revenue to reach 36.27B, while the EPS is projected at 5.34. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HUM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HUM's stock price typically moves by 5.2% in the 10 days before its earnings and 1.51% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 5.34 and revenue of 36.27B.

The earnings call summary indicates strong financial performance with a 12% YoY revenue increase, a 15% rise in operating cash flow, and a 10% increase in net income. EPS also grew significantly, supported by share repurchases. The improvement in the Medical Expense Ratio suggests effective cost management. Although there were no operational or strategic updates, the financial metrics alone suggest a positive outlook. Without Q&A insights, the financials remain the primary positive driver.